Evaluation of a Routine Second Transurethral Resection of the Bladder (TURBT) After Primary Complete Blue Light TURBT in Patients With Non-muscle Invasive Intermediate- and High-risk Urothelial Bladder Cancer: a Prospective, Randomized, Multicenter Study

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT07906626

Title field or adapter rule

{'original_value': 'Evaluation of a Routine Second Transurethral Resection of the Bladder (TURBT) After Primary Complete Blue Light TURBT in Patients With Non-muscle Invasive Intermediate- and High-risk Urothelial Bladder Cancer: a Prospective, Randomized, Multicenter Study', 'source_field': 'protocolSection.identificationModule.officialTitle'}

Ingested At

2026-10-31T23:27:28.237206+00:00

Published At

2026-10-30T00:00:00+00:00

Record Updated At

2026-10-30

Source Retrieved At

2026-10-31T22:18:03.495925+00:00

Timestamp Basis

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Date limitation

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Lung Cancer (NSCLC)"]

protocolSection.statusModule.lastUpdatePostDateStruct

{"date": "2026-10-30", "type": "ACTUAL"}

protocolSection.identificationModule.nctId

"NCT07906626"

protocolSection.identificationModule.officialTitle

"Evaluation of a Routine Second Transurethral Resection of the Bladder (TURBT) After Primary Complete Blue Light TURBT in Patients With Non-muscle Invasive Intermediate- and High-risk Urothelial Bladder Cancer: a Prospective, Randomized, Multicenter Study"

protocolSection.statusModule.overallStatus

"COMPLETED"

protocolSection.designModule.phases

["NA"]

protocolSection.statusModule.resultsFirstPostDateStruct

null

Study condition terms

• Lung Cancer (NSCLC) (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

• {'armGroupLabels': ['INTERVENTION'], 'description': 'Participants in the intervention group received 2 capsules 3 times daily for 3 months (9 Weeks). Each capsule contained 500 mg of Channa striata extract and 50 mg of curcumin (Striatamin®; PT Mega Medica, Jakarta, Indonesia), providing a total daily dose of 3000 mg of C. striata extract and 300 mg of curcumin.', 'name': 'Snakehead Fish Extract and Curcumin', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

Drug names recorded in this source

• Snakehead Fish Extract and Curcumin (protocolSection.armsInterventionsModule.interventions[].name)

A recorded drug name is not by itself an indication or a condition-specific relationship.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.